EndoChoice, De Lage Landen Financial Services collaborate, Spring Bank Pharmaceutical appoints CMO — 4 GI/endoscopy company key notes

Here are four news updates on key gastroenterology and endoscopy companies.

Advertisement

EndoChoice has a consensus revenue estimate of $74.51 million for fiscal year 2015.

EndoChoice is collaborating with De Lage Landen Financial Services to create a new financing option for customers interested in its Fuse Endoscopy system.

Clinical-stage biopharmaceutical company Spring Bank Pharmaceutical appointed Nezam Afdhal, MD, CMO.

Olympus introduced its CleverCut3V Distal Wireguided sphincterotome.

More articles on GI/endoscopy:
Exact Sciences to open biotech campus & more – 3 GI company key notes
CMS cuts to colonoscopy reimbursement finalized: 3 things to know
6 recent must-reads on CRC screening & treatments

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.